1.A Case of Congenital Patent Urachus.
Baik Nam CHOI ; Chong Kook LIM ; Hyen Jai NA ; Cheon Kui SONG ; Su Bang RYU ; Eun Ho KIM
Korean Journal of Urology 1980;21(4):373-376
Urachal anomalies are very rare. The umbilicus and the structures which lead to its formation rarely cause trouble except in patients with an error. Embryologically, the urachus represents the vestigial remnant of the allantois which, in the fetus, communicates with the cloaca. The patent urachus results from failure of luminal closure of the urachus Herein a case of congenital patent urachus reported with a brief review of literatures.
Allantois
;
Cloaca
;
Fetus
;
Humans
;
Phenobarbital
;
Umbilicus
;
Urachus*
2.A Case of Complete Regression of Hepatocellular Carcinoma during Administration of COX-2 Inhibitor.
Hae Jung SONG ; Yun Soo KIM ; Chang Hee HAN ; Jae Young JANG ; Jung Hoon KIM ; Young Koog CHEON ; Young Seok KIM ; Jong Ho MOON ; Young Deok CHO ; Chan Sup SHIM ; Kui Hyang KWON ; Boo Sung KIM
The Korean Journal of Hepatology 2006;12(3):449-454
Overexpression of cyclooxygenase-2 (COX-2) has been associated with hepatocarcinogenesis. Inhibitors of COX-2 have proapoptotic and antiproliferative effects on malignant tumors and inhibit tumor invasion to the surrounding tissues. We report here a case of complete regression of advanced hepatocellular carcinoma (HCC) during COX-2 inhibitor administration. An eighty-year-old female was diagnosed as an advanced HCC, which was associated with HCV infection. She received COX-2 inhibitor for 3 months due to degenerative arthritis of both knees. Tumor enhancement on arterial phase CT completely disappeared without specific treatment for the HCC, and the tumor size decreased on the follow-up CT scan.
Aged, 80 and over
;
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
;
Carcinoma, Hepatocellular/*drug therapy
;
Cyclooxygenase 2 Inhibitors/administration & dosage/*therapeutic use
;
Diclofenac/administration & dosage/analogs & derivatives/therapeutic use
;
Female
;
Humans
;
Lactones/administration & dosage/therapeutic use
;
Liver Neoplasms/*drug therapy
;
Pyrazoles/administration & dosage/therapeutic use
;
Sulfonamides/administration & dosage/therapeutic use
;
Sulfones/administration & dosage/therapeutic use